R+D in neuroscience and neurotechnology

We strive to translate neuroscientific discoveries into neurotechnology products and services improving overall brain-health and well-being. Our R+D Program is the first stage in market translation of breakthrough research. Our neuroscience research aims to leverage EEG and TES as non-invasive, fast, and cost-effective tools for the observation and treatment of the brain, finding novel biomarkers and stimulation approaches through cutting edge AI-powered analytics for innovative and impactful neurotechnology solutions.

 

 

Biomarker Research Discovery

​

With the extensive EEG expertise of our team of neuroscientists, we have achieved significant advancements in identifying neural markers associated with emotions, well-being, cognitive performance, and consciousness. Our research into neurodegenerative diseases, neurodevelopmental disorders, and brain health has resulted in the discovery of biomarkers that enable the stratification and early diagnosis of conditions such as Parkinson’s disease. Through ongoing research and collaborative efforts, we continuously validate and expand our biomarker toolkit, advancing towards early, precise, and personalized medicine.

 

​

Personalized non-invasive brain stimulation

Starlab pioneered the development of the first multi-site Transcranial Electrical Stimulation (TES) devices. Today, our expertise is employed to advance precise, and personalized medicine. We have developed different integrated systems for stroke rehabilitation. Additionally, our AI-analytics pipeline is currently offered to stratify the application of Non-Invasive Brain Stimulation, optimizing treatment outcomes for individual patients.

 

​

Advanced Protocol and Application Development

We leverage the latest findings in neuroscience research to develop cutting-edge protocols and solutions that address current brain-related health challenges. Our neural markers have been instrumental in numerous projects. For instance, in a collaboration with the Michael J Fox Foundation, we developed a decision support system to detect Parkinson’s disease as early as 8 years before its diagnosis. In the STIPED and AIMS2 Trials projects, in collaboration with Neuroelectrics, we have developed advanced biomarker-based brain stimulation protocols. Additionally, our emotional markers are being utilized in the eMOTIONAL Cities project to improve urban design through neuro-informed decisions. 

​

Discover more about our groundbreaking R&D efforts and applications by exploring the links below.